SD
Srikripa Devarakonda Truist Securities Latest Price Targets & Analyst Ratings
Main Sector
Healthcare
Ratings Past Year
30
Avg Return
Past Year
Past Year
25%
Success Rate
Past Year
Past Year
0
%
Rating Distribution
Past 3 Months
Positive
91.7%
Neutral
8.3%
Negative
0%
Past Week
Past Month
Past 3 Months
Past 6 Months
Past Year
All Time
Positive
Neutral
Negative
Mega Cap
Over $200B
Large Cap
$10B to $200B
Mid Cap
$2B to $10B
Small Cap
$250M to $2B
Micro Cap
Under $250M
Healthcare
Healthcare
Biotechnology
Drug Manufacturers - General
Drug Manufacturers - Specialty & Generic
| Stock | Rating | Price Target |
Upside Downside |
Ratings 3 Months |
Avg Return 1 Year |
Success Rate 1 Year | Date | |
|---|---|---|---|---|---|---|---|---|
|
Buy
Maintained
| $80 |
21%
upside
| 2 | +6.8% |
0
%
| 26 Nov ‘25 8 days ago |
|
|
|
Buy
Maintained
| $35 |
29%
upside
| 3 | +56% |
0
%
| 19 Nov ‘25 15 days ago |
|
|
|
Buy
Maintained
| $640 |
9%
upside
| 2 | +17% |
0
%
| 19 Nov ‘25 15 days ago |
|
|
|
Hold
Reiterated
| $93 |
7%
downside
| 1 | – |
–
| 29 Oct ‘25 1 month ago |
|
|
|
Buy
Maintained
| $88 |
0%
upside
| 1 | +26% |
0
%
| 28 Oct ‘25 1 month ago |
|
|
|
Buy
Maintained
| $44 |
3%
downside
| 1 | +62% |
0
%
| 20 Oct ‘25 1 month ago |
|
|
|
Buy
Initiated
| $15 |
40%
upside
| 1 | +7.9% |
0
%
| 15 Oct ‘25 1 month ago |
|
|
|
Buy
Initiated
| $50 |
55%
upside
| 1 | +140% |
0
%
| 15 Oct ‘25 1 month ago |
|